全基因组分析发现心肌梗死新易感位点
1p21.3区域SLC44A3与冠心病背景下的心肌梗死关联获日本生物银行及16个血管造影队列验证,提示其参与易损斑块病理生理。
要点
- 8个新心肌梗死易感区域被鉴定,6个对心肌梗死效应强于无心肌梗死的冠心病
- SLC44A3位点与冠心病背景下的心肌梗死关联,但与冠状动脉粥样硬化本身无关
- SLC44A3在缺血冠状动脉及白细胞介素-1β处理的内皮细胞中表达上调
核心结论
- 大规模分析揭示心肌梗死新遗传决定因素,并提示SLC44A3参与易损斑块病理生理。
主要发现
- 8个新区域达全基因组显著水平,其中6个对心肌梗死效应强于无心肌梗死的冠心病。
- 1p21.3区域SLC44A3与冠心病背景下的心肌梗死关联获验证,但与冠状动脉粥样硬化本身无关。
- SLC44A3位点与冠心病危险因素、凝血生物标志物、其他血栓疾病及包括胆碱、氧化三甲胺和甜菜碱在内的代谢物水平无关。
- 携带心肌梗死风险等位基因者主动脉SLC44A3表达增加,缺血冠状动脉较非病变冠状动脉表达增加。
- 人主动脉内皮细胞经白细胞介素-1β处理较溶媒对照SLC44A3上调,且与体外平滑肌细胞迁移相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: While most patients with myocardial infarction (MI) have underlying coronary atherosclerosis, not all patients with coronary artery disease (CAD) develop MI. We sought to address the hypothesis that some of the genetic factors which establish atherosclerosis may be distinct from those that predispose to vulnerable plaques and thrombus formation. METHODS AND RESULTS: We carried out a genome-wide association study for MI in the UK Biobank (n∼472 000), followed by a meta-analysis with summary statistics from the CARDIoGRAMplusC4D Consortium (n∼167 000). Multiple independent replication analyses and functional approaches were used to prioritize loci and evaluate positional candidate genes. Eight novel regions were identified for MI at the genome wide significance level, of which effect sizes at six loci were more robust for MI than for CAD without the presence of MI. Confirmatory evidence for association of a locus on chromosome 1p21.3 harbouring choline-like transporter 3 (SLC44A3) with MI in the context of CAD, but not with coronary atherosclerosis itself, was obtained in Biobank Japan (n∼165 000) and 16 independent angiography-based cohorts (n∼27 000). Follow-up analyses did not reveal association of the SLC44A3 locus with CAD risk factors, biomarkers of coagulation, other thrombotic diseases, or plasma levels of a broad array of metabolites, including choline, trimethylamine N-oxide, and betaine. However, aortic expression of SLC44A3 was increased in carriers of the MI risk allele at chromosome 1p21.3, increased in ischaemic (vs. non-diseased) coronary arteries, up-regulated in human aortic endothelial cells treated with interleukin-1β (vs. vehicle), and associated with smooth muscle cell migration in vitro. CONCLUSIONS: A large-scale analysis comprising ∼831 000 subjects revealed novel genetic determinants of MI and implicated SLC44A3 in the pathophysiology of vulnerable plaques.
引用
- Hartiala JA, Han Y, Jia Q, et al. Genome-wide analysis identifies novel susceptibility loci for myocardial infarction. Eur Heart J. 2021. PMID: 33532862. doi:10.1093/eurheartj/ehaa1040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。